{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T01:17:12Z","timestamp":1760577432535,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010400","name":"Children's Mercy Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010400","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ward Family Heart Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00228-019-02697-y","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T06:02:19Z","timestamp":1559800939000},"page":"1227-1235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-6895","authenticated-orcid":false,"given":"Kayode","family":"Ogungbenro","sequence":"first","affiliation":[]},{"given":"Jonathan B.","family":"Wagner","sequence":"additional","affiliation":[]},{"given":"Susan","family":"Abdel-Rahman","sequence":"additional","affiliation":[]},{"given":"J. Steven","family":"Leeder","sequence":"additional","affiliation":[]},{"given":"Aleksandra","family":"Galetin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"3","key":"2697_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2165\/00003088-199324030-00002","volume":"24","author":"VF Mauro","year":"1993","unstructured":"Mauro VF (1993) Clinical pharmacokinetics and practical applications of simvastatin. Clin Pharmacokinet 24(3):195\u2013202","journal-title":"Clin Pharmacokinet"},{"issue":"9753","key":"2697_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376(9753):1670\u20131681","journal-title":"Lancet"},{"issue":"12","key":"2697_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","volume":"316","author":"MG Silverman","year":"2016","unstructured":"Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS (2016) Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA 316(12):1289\u20131297","journal-title":"JAMA"},{"issue":"13","key":"2697_CR4","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","volume":"289","author":"PD Thompson","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH (2003) Statin-associated myopathy. JAMA 289(13):1681\u20131690","journal-title":"JAMA"},{"issue":"1","key":"2697_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/clpt.2014.55","volume":"96","author":"N Tsamandouras","year":"2014","unstructured":"Tsamandouras N, Dickinson G, Guo Y, Hall S, Rostami-Hodjegan A, Galetin A, Aarons L (2014) Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach. Clin Pharmacol Ther 96(1):90\u2013100","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"2697_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1124\/dmd.30.5.505","volume":"30","author":"T Prueksaritanont","year":"2002","unstructured":"Prueksaritanont T, Subramanian R, Fang X, Ma B, Qiu Y, Lin JH, Pearson PG, Baillie TA (2002) Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Drug Metab Dispos 30(5):505\u2013512","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"2697_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1124\/dmd.110.032649","volume":"38","author":"M Gertz","year":"2010","unstructured":"Gertz M, Harrison A, Houston JB, Galetin A (2010) Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. Drug Metab Dispos 38(7):1147\u20131158","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"2697_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0002-9149(99)00442-7","volume":"84","author":"PJK Gruer","year":"1999","unstructured":"Gruer PJK, Vega JM, Mercuri MF, Dobrinska MR, Tobert JA (1999) Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin. Am J Cardiol 84(7):811\u2013815","journal-title":"Am J Cardiol"},{"issue":"1","key":"2697_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/clpt.2012.57","volume":"92","author":"RA Wilke","year":"2012","unstructured":"Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M (2012) The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin Pharmacol Ther 92(1):112\u2013117","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2697_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/clpt.2014.125","volume":"96","author":"LB Ramsey","year":"2014","unstructured":"Ramsey LB, Johnson SG, Caudle KE, Haidar CE, Voora D, Wilke RA, Maxwell WD, McLeod HL, Krauss RM, Roden DM, Feng Q, Cooper-DeHoff RM, Gong L, Klein TE, Wadelius M, Niemi M (2014) The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharmacol Ther 96(4):423\u2013428","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"2697_CR11","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R (2008) SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med 359(8):789\u2013799","journal-title":"N Engl J Med"},{"doi-asserted-by":"crossref","unstructured":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report (2011). Pediatrics 128(Suppl 5):S213\u2013256","key":"2697_CR12","DOI":"10.1542\/peds.2009-2107C"},{"issue":"6","key":"2697_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamapediatrics.2015.0168","volume":"169","author":"HC Gooding","year":"2015","unstructured":"Gooding HC, Rodday A, Wong JB et al (2015) Application of pediatric and adult guidelines for treatment of lipid levels among us adolescents transitioning to young adulthood. JAMA Pediatr 169(6):569\u2013574","journal-title":"JAMA Pediatr"},{"issue":"12","key":"2697_CR14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157\u20131167","journal-title":"N Engl J Med"},{"issue":"6","key":"2697_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/jcph.1080","volume":"58","author":"JB Wagner","year":"2018","unstructured":"Wagner JB, Abdel-Rahman S, Van Haandel L, Gaedigk A, Gaedigk R, Raghuveer G, Kauffman R, Leeder JS (2018) Impact of SLCO1B1 genotype on pediatric simvastatin acid pharmacokinetics. J Clin Pharmacol 58(6):823\u2013833","journal-title":"J Clin Pharmacol"},{"key":"2697_CR16","first-page":"1989","volume-title":"NONMEM User's Guides","author":"S Beal","year":"2009","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ (2009) NONMEM User's Guides. Icon Development Solutions, Ellicott City, pp 1989\u20132009"},{"unstructured":"MATLAB R2017a (9.2.0.556344). The MathWorks Inc, Natick","key":"2697_CR17"},{"issue":"7","key":"2697_CR18","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s11095-013-1284-0","volume":"31","author":"S-J Jin","year":"2014","unstructured":"Jin S-J, Bae K-S, Cho S-H, Jung J-A, Kim U, Choe S, Ghim J-L, Noh Y-H, Park H-J, H-s K, Lim H-S (2014) Population pharmacokinetic analysis of simvastatin and its active metabolite with the characterization of atypical complex absorption kinetics. Pharm Res 31(7):1801\u20131812","journal-title":"Pharm Res"},{"issue":"5","key":"2697_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28(5):481\u2013504","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"2697_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40262-017-0579-4","volume":"57","author":"A van Rongen","year":"2018","unstructured":"van Rongen A, Brill MJE, Vaughns JD, Valitalo PAJ, van Dongen EPA, van Ramshorst B, Barrett JS, van den Anker JN, Knibbe CAJ (2018) Higher midazolam clearance in obese adolescents compared with morbidly obese adults. Clin Pharmacokinet 57(5):601\u2013611","journal-title":"Clin Pharmacokinet"},{"doi-asserted-by":"crossref","unstructured":"van Rongen A, van der Aa MP, Matic M, van Schaik RHN, Deneer VHM, van der Vorst MM, Knibbe CAJ (2018) Increased metformin clearance in overweight and obese adolescents: a pharmacokinetic substudy of a randomized controlled trial. Pediatr Drugs 20(4):365\u2013374","key":"2697_CR21","DOI":"10.1007\/s40272-018-0293-1"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02697-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:32:15Z","timestamp":1591313535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2697"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02697-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for the study was approved by the Children\u2019s Mercy Hospital Institutional Review Board. Written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}